Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.

Patients newly admitted to rehabilitation centres are at high risk of colonization with multidrug-resistant bacteria because many of them have experienced prolonged stays in other healthcare settings and have had high exposure to antibiotics. We conducted a prospective study to determine the prevalence of and risk factors for colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in this population. Subjects were screened by rectal swab for ESBL-PE within 2 days of admission. Swabs were plated on chromagar ESBL plates and the presence of ESBL was verified by a central laboratory. A multilevel mixed effects model was used to identify risk factors for ESBL-PE colonization. Of 2873 patients screened, 748 (26.0%) were positive for ESBL-PE. The variables identified as independently associated with ESBL-PE colonization were: recent stay in an acute-care hospital for over 2 weeks (OR=1.34; 95% CI, 1.12, 1.6), history of colonization with ESBL-PE (OR=2.97; 95% CI, 1.99, 4.43), unconsciousness on admission (OR=2.59; 95% CI, 1.55, 4.34), surgery or invasive procedure in the past year (OR=1.49; 95% CI, 1.2, 1.86) and antibiotic treatment in the past month (OR=1.80; 95% CI, 1.45, 2.22). The predictive accuracy of the model was low (area under the ROC curve 0.656). These results indicate that ESBL-PE colonization is common upon admission to rehabilitation centres. Some risk factors for ESBL-PE colonization are similar to those described previously; however, newly identified factors may be specific to rehabilitation populations. The high prevalence and low ability to stratify by risk factors may guide infection control and empirical treatment strategies in rehabilitation settings.

[1]  V. Jarlier,et al.  Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  Y. Glupczynski,et al.  Evaluation of Brilliance ESBL Agar, a Novel Chromogenic Medium for Detection of Extended-Spectrum-Beta- Lactamase-Producing Enterobacteriaceae , 2010, Journal of Clinical Microbiology.

[3]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[4]  R. Raz,et al.  Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[5]  Y. Carmeli,et al.  Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  M. Falagas,et al.  Extended-spectrum b-lactamase-producing organisms , 2022 .

[7]  N. Woodford,et al.  Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  S. Vimont,et al.  CTX-M β-lactamase–producing Escherichia coli in Long-term Care Facilities, France , 2004, Emerging infectious diseases.

[9]  G. Chung,et al.  High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea. , 2010, Diagnostic microbiology and infectious disease.

[10]  H. Goossens,et al.  Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  D. Mehr,et al.  Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  I. Brook,et al.  Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections , 2010, Chemotherapy.

[13]  H. Goossens,et al.  Comparative Population Analysis of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Colonizing Patients in Rehabilitation Centers in Four Countries , 2013, Antimicrobial Agents and Chemotherapy.

[14]  H. Goossens,et al.  Clonal Structure, Extended-Spectrum β-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four Countries , 2012, Antimicrobial Agents and Chemotherapy.

[15]  W. Bilker,et al.  Colonization with Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species in Long-Term Care Facility Residents , 2012, Infection Control & Hospital Epidemiology.